(Q36519068)

14 August 2017

1 reference

title

The treatment of the rheumatological manifestations of the inflammatory bowel diseases (English)

1 reference

inflammatory bowel diseases

14 August 2017

main subject

0 references

author name string

Melissa Padovan

1

1 reference

14 August 2017

Gabriella Castellino

2

1 reference

14 August 2017

Marcello Govoni

3

1 reference

14 August 2017

Francesco Trotta

4

1 reference

14 August 2017

publication date

24 June 2006

1 reference

Rheumatology International

14 August 2017

published in

1 reference

14 August 2017

volume

26

1 reference

14 August 2017

issue

11

1 reference

14 August 2017

page(s)

953-958

1 reference

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

14 August 2017

cites work

1 reference

12 December 2020

Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

The effect of infliximab on extraintestinal manifestations of Crohn's disease

1 reference

12 December 2020

Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study.

1 reference

12 December 2020

Bowel inflammation and the spondyloarthropathies

1 reference

12 December 2020

Enteropathic arthritis

1 reference

12 December 2020

Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial

1 reference

12 December 2020

Which is the active moiety of sulfasalazine in ankylosing spondylitis? A randomized, controlled study

1 reference

12 December 2020

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

1 reference

12 December 2020

Methotrexate for ankylosing spondylitis

1 reference

12 December 2020

Immune linkages between inflammatory bowel disease and spondyloarthropathies

1 reference

12 December 2020

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

1 reference

12 December 2020

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms

1 reference

12 December 2020

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

12 December 2020

Why do patients with ulcerative colitis relapse?

1 reference

12 December 2020

Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging

1 reference

12 December 2020

Mesalamine therapy in Reiter's syndrome

1 reference

12 December 2020

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

1 reference

12 December 2020

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

1 reference

12 December 2020

Six months open label trial of leflunomide in active ankylosing spondylitis

1 reference

12 December 2020

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

1 reference

12 December 2020

Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel

1 reference

12 December 2020

Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial

1 reference

12 December 2020

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis

1 reference

12 December 2020

Ankylosing spondylitis and bowel disease

1 reference

12 December 2020

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

12 December 2020

1 reference

12 December 2020

Crohn's disease arthritis treated with infliximab: an open trial in four patients

1 reference

12 December 2020

Ileocolonoscopic findings in seronegative spondylarthropathies

1 reference

12 December 2020

How to diagnose axial spondyloarthropathy early

1 reference

12 December 2020

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial

1 reference

12 December 2020

Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial

1 reference

12 December 2020

One-year open-label trial of thalidomide in ankylosing spondylitis

1 reference

12 December 2020

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

1 reference

12 December 2020

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

1 reference

12 December 2020

Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis

1 reference

12 December 2020

Inflammatory bowel disease and spondylarthropathy

1 reference

12 December 2020

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

12 December 2020

The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.

1 reference

12 December 2020

Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation

1 reference

12 December 2020

Tissue cytokine and chemokine expression in inflammatory bowel disease

1 reference

12 December 2020

10.1007/S00296-006-0148-X

Identifiers

DOI

1 reference

14 August 2017

1 reference